The tobacco marketplace has changed with the introduction of new nicotine delivery devices. While the public health community has been addressing the dramatic increase of e-cigarette use among youth, FDA recently conducted qualitative research with adult smokers to ascertain their current attitudes and beliefs about cigarettes and other tobacco products. Focus group findings underscore that… Read more »
Archives: Seminars
Can we have a simultaneous compassionate and dispassionate approach to vaping?
Globally, tobacco control researchers, policy makers, advocates etc are passionate and often united in working towards ending the smoking epidemic, though we choose to take different paths to achieve this ambition. The UK has taken a compassionate approach to vaping, including for groups for whom there is a very high smoking prevalence, such as people who… Read more »
Introduction
Lunch
21st Century Tobacco Control: Putting Public Health First
A myriad of studies find that tobacco control policies targeting e-cigarettes can increase combustible tobacco use, presumably by reducing incentives to choose vaping over smoking. Given evidence that vaping nicotine is likely far less harmful than smoking combustible cigarettes, these unintended consequences may translate into substantial costs for population health. This presentation will summarize published… Read more »
Break
A clinician’s perspective: Addressing tobacco cessation and harm reduction in the wake of an “annus horibilis” (or a year like no other)
2020 was a year like no other. The COVID-19 pandemic affected everyone but especially challenged health care systems. The social unrest of the “Black Lives Matter” movement led health care systems to increase focus on reducing causes of health disparities and addressing institutional racism. New research on e-cigarettes and clinical guidelines on tobacco treatment continued… Read more »
A targeted approach to using electronic cigarettes for harm reduction in adults
As the debate unfolds on how best to prevent adolescents from using electronic cigarettes, we have lost sight of their potential for harm reduction in adult smokers. Despite decades of availability of evidence-based smoking cessation medications, many adults continue to smoke. In some populations, such as people with COPD, mental health diagnoses or HIV infection,… Read more »
The evidence on e-cigarettes for smoking cessation: when is enough enough?
The evidence on the use of e-cigarettes to help adults who smoke quit combustible tobacco is growing year on year. Cochrane reviews are accepted as the gold-standard for investigating the evidence of potential harms and benefits of healthcare interventions. This talk will cover the most recent evidence from the Cochrane living systematic review of e-cigarettes… Read more »
Keynote: Balancing Consideration of the Risks and Benefits of E-Cigarettes
Regarding e-cigarettes, most US health organizations, media coverage, and policymakers focus on risks to youth. Due to their messaging, much of the public – including smokers – incorrectly consider vaping as dangerous as smoking. Policies intended to reduce adolescent vaping may also reduce adult smokers’ use of e-cigarettes in quit attempts. Because evidence indicates that… Read more »
Recent Comments